柳药集团：累计回购股份数量为977.46万股

Summary of Key Points Core Viewpoint - Liu Pharmaceutical Group announced a share buyback program, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1]. Company Actions - As of October 31, 2025, the company has repurchased a total of 9.7746 million shares [1]. - The repurchased shares represent 2.46% of the company's total share capital, an increase of 0.42% compared to the previous announcement [1]. - The highest price paid for the repurchased shares was 19.07 yuan per share, while the lowest was 17.83 yuan per share [1]. - The total amount spent on the buyback is approximately 180 million yuan [1].